Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
$0.56−0.04 (-7.07%)
Close on Nov 17, 2026Market cap $1.45MP/E –Yield –
Calidi Biotherapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Calidi Biotherapeutics's operating margin for the twelve months ending Dec 31, 2022 was -51395.6%. For fiscal 2022 it was -51395.6%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -51395.6% | – |
See a number that looks wrong?